THE RISK OF CORONARY ARTERY DISEASE DEVELOPMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS (BECHTEREW’S DISEASE) AND PSORIATIC ARTHRITIS: A 10-YEAR PROSPECTIVE FOLLOW-UP STUDY

THE RISK OF CORONARY ARTERY DISEASE DEVELOPMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS (BECHTEREW’S DISEASE) AND PSORIATIC ARTHRITIS: A 10-YEAR PROSPECTIVE FOLLOW-UP STUDY

Objective: assessment of coronary artery disease (CAD) incidence among patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) without manifestation of cardiovascular diseases.Materials and methods. We analyzed the data of 10-year prospective follow-up of the patient with AS (n = 278...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. Z. Gaidukova, A. P. Rebrov
Format:	Article
Language:	Russian
Published:	ABV-press 2017-01-01
Series:	Klinicist
Subjects:	coronary artery disease myocardial infarction stenocardia arterial hypertension cardiovascular risk spondyloarthritis ankylosing spondylitis psoriatic arthritis c-reactive protein nonsteroidal anti-inflammatory drugs antihypertensive therapy
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/273
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
by: A. P. Rebrov, et al.
Published: (2015-03-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
by: T. V. Dubinina, et al.
Published: (2023-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
by: E. E. Gubar, et al.
Published: (2023-08-01)

Diagnosis of spondyloarthritis: should we need new criteria?
by: I. Z. Gaidukova, et al.
Published: (2015-03-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
by: M. M. Baranova, et al.
Published: (2024-06-01)

Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme
by: Ran Jin, et al.
Published: (2025-03-01)

THE BASIC PRINCIPLES OF TREATMENT OF ANKYLOSING SPONDYLITIS (BECHTEREW'S DISEASE)
by: Shandor Fedorovich Erdes
Published: (2014-02-01)

Changing the concept of spondyloarthritis: Characteristics of teaching when changing the paradigm in a particular area of medical knowledge
by: I. Z. Gaydukova, et al.
Published: (2017-04-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

«TREAT-TO-TARGET» (T2T) STRATEGY IN SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2014-06-01)

PALLIATIVE CARE IN SPONDYLOARTHRITIS: IS THERE A NEED FOR THIS?
by: A. P. Rebrov, et al.
Published: (2015-04-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01)

THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01)

Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis
by: Rimma Mikhailovna Balabanova, et al.
Published: (2014-12-01)

Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis
by: Aleksandr Viktorovich Smirnov
Published: (2013-06-01)

STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
by: I. Z. Gaidukova, et al.
Published: (2016-12-01)

Modern imaging techniques in the diagnosis of axial spondylitis: similarities and differences between axial psoriatic arthritis and ankylosing spondylitis
by: A. V. Sukhinina, et al.
Published: (2024-02-01)

Ankylosing spondylitis morbidity trends in Russia and Saturday spondyloarthritis schools
by: Shandor Fedorovich Erdes, et al.
Published: (2013-04-01)

Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis
by: A A Godzenko
Published: (2011-12-01)

Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
by: Ploysyne Rattanakaemakorn, et al.
Published: (2024-11-01)

Remission in ankylosing spondylitis and axial spondyloarthritides: A modern understanding of the problem
by: I. Z. Gaydukova, et al.
Published: (2016-03-01)

PSORIATIC ARTHRITIS: AN ALGORITHM FOR MAKING A DECISION ON THE CHOICE OF MANAGEMENT TACTICS
by: N. A. Shostak, et al.
Published: (2016-03-01)

Symptom modifiers in therapy for ankylosing spondylitis
by: V. V. Badokin
Published: (2010-06-01)

COMMENTS ON THE ARTICLE «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» PUBLISHED IN No4, 2013
by: A. P. Rebrov, et al.
Published: (2014-06-01)

Individuals with reactive arthritis suffer from poor health-related quality of life akin to individuals with ankylosing spondylitis: A multigroup study
by: Prakash Gupta, et al.
Published: (2022-01-01)

VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA
by: A. I Akulova, et al.
Published: (2018-07-01)

Treatment of ankylosing spondylitis during pregnancy
by: O. A. Krichevskaya, et al.
Published: (2021-07-01)

Coexistence of Ankylosing Spondylitis, Metabolic Syndrome and Gout Disease
by: Erkan Kozanoğlu, et al.
Published: (2025-01-01)

Frequency of scapular dyskinesis and its relationship with disease parameters in patients with ankylosing spondylitis: a cross-sectional study
by: Sertaç Ketenci, et al.
Published: (2025-04-01)

Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01)

CLINICAL HETEROGENEITY OF EARLY PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2016-12-01)

Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)

COMPARATIVE EVALUATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
by: I. А. Cherentsova, et al.
Published: (2016-09-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Comorbid Infections in Spondyloarthritis: the Current State of the Problem
by: M. M. Baranova, et al.
Published: (2025-04-01)

EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY
by: T. A. Raskina, et al.
Published: (2016-09-01)